| Literature DB >> 35072396 |
Karen Amanda Soares de Oliveira1, Ana Carolina Dos Santos Lousa1, Marcos Loiola de Souza1, Tércio Campos Leão2, Jeffchandler Belém de Oliveira2, Lucas Henrique Prado Sousa2, Arlindo Rodrigues Galvão3, Rodrigo Oliveira Rosa Ribeiro de Souza4.
Abstract
INTRODUCTION: In minimally invasive mitral valve repair, right minithoracotomy is the most widely performed method, providing a good view of the mitral valve. But regarding other techniques and although it offers limited visualization, the periareolar access is a less traumatic alternative. This study's purpose is to compare in-hospital outcomes in patients who underwent video-assisted minimally invasive mitral valve repair via right minithoracotomy and periareolar access.Entities:
Keywords: Airway Extubation; Cardiac Surgical Procedures; Drainage; Intensive Care Units; Length of Stay; Mitral Valve; Thoracic Surgery; Thoracotomy
Mesh:
Year: 2022 PMID: 35072396 PMCID: PMC8973132 DOI: 10.21470/1678-9741-2020-0507
Source DB: PubMed Journal: Braz J Cardiovasc Surg ISSN: 0102-7638
Fig. 1(A) Right minithoracotomy and (B) periareolar access incisions for minimally invasive mitral valve surgery.
Baseline characteristics of patients who underwent MIS mitral valve repair via RT and PA.
| Characteristic | RT (n=21) | PA (n=16) | |
|---|---|---|---|
| Age (years) | 62.33±12.04 | 61.37±9.99 | 0.20 |
| Male, n (%) | 18 (85.71%) | 11 (68.75%) | 0.21 |
| Female, n (%) | 3 (14.28%) | 5 (31.25%) | |
| LVEF (%) | 57.90±9.26 | 54.62±9.26 | 0.17 |
| EuroSCORE II (%) | 4.03±7.12 | 4.60±8,12 | 0.56 |
| Hematocrit (%) | 33.33±2.08 | 32.75±2.59 | 0.16 |
Intraoperative and in-hospital postoperative outcomes of patients who underwent MIS mitral valve repair via RT and PA.
| Outcome | RT (n=21) | PA (n=16) | |
|---|---|---|---|
| Intraoperative outcomes | |||
| Incision length (cm) | 3.71±0.64 | 4.25±1.06 | 0.25 |
| CPB time (minutes) | 113.52±30.45 | 119.31±32.33 | 0.84 |
| Aortic cross-clamping time (minutes) | 81.33±18.41 | 82.06±21.84 | 0.28 |
| Conversion to sternotomy, n (%) | 0 (0%) | 0 (0%) | - |
| In-hospital postoperative outcomes | |||
| Time to extubation (hours) | 4.85±1.71 | 5.62±1.08 | 0.04 |
| Chest tube drainage (ml/24 hours) | 323.81±139.3 | 309.37±162.5 | 0.43 |
| Transfusion of red blood, n (%) | 0 (0%) | 0 (0%) | - |
| ICU length of stay (hours) | 34±16.46 | 29.62±16.6 | 0.54 |
| Total length of stay (days) | 4.09±0.53 | 4.25±0.44 | 0.79 |
| Hematocrit (%) | 33.33±2.08 | 32.75±2.59 | 0.16 |
| In-hospital death, n (%) | 0 (0%) | 0 (0%) | - |
| Abbreviations, acronyms & symbols | |
|---|---|
| CPB | = Cardiopulmonary bypass |
| EuroSCORE | = European System for Cardiac Operative Risk Evaluation |
| ICU | = Intensive care unit |
| LVEF | = Left ventricular ejection fraction |
| MIS | = Minimally invasive surgery |
| PA | = Periareolar access |
| RT | = Right minithoracotomy |
| Authors' roles & responsibilities | |
|---|---|
| KASO | Substantial contributions to the conception and design of the work; and the analysis or interpretation of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| ACSL | Drafting the work or revising it critically for important intellectual content; final approval of the version to be published |
| MLS | Substantial contributions to the analysis or interpretation of data for the work; final approval of the version to be published |
| TCLN | Substantial contributions to the acquisition of data for the work; final approval of the version to be published |
| JBO | Substantial contributions to the acquisition of data for the work; final approval of the version to be published |
| LHPS | Substantial contributions to the acquisition of data for the work; final approval of the version to be published |
| ARGF | Substantial contributions to the analysis and interpretation of data for the work; final approval of the version to be published. |
| RORRS | Substantial contributions to the acquisition of data for the work; drafting the work or revising it critically for important intellectual content; final approval of the version to be published |